Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Myelin expression factor 2 (MYEF2) is a transcriptional repressor protein primarily located in the nucleus, encoded by the MYEF2 gene on human chromosome 15. It represses the transcription of the myelin basic protein (MBP) gene by binding to the MB1 element of the MBP promoter, playing a role in brain development and neuronal differentiation. MYEF2 also has RNA binding activity and is involved in myotube differentiation. It is overexpressed in hepatocellular carcinoma and other cancers, promoting cell migration and invasion, and is emerging as a biomarker associated with tumor progression and prognosis, especially in liver cancer.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myelin expression factor 2 (MYEF2).